Changfeng Announces Hong Kong IPO Update and Declaration of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
19
Changfeng Announces Hong Kong IPO Update and Declaration of Semi-annual and Special Dividends

TORONTO, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Changfeng Energy Inc., (TSXV: CFY) (“Changfeng” or the “Company”, together with its subsidiaries the “Group”), an energy provider in the People’s Republic of China (the “PRC”), announces the following:

HK IPO

As previously announced, the Company has been pursuing an initial public offering of its common shares on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) (the “HK IPO”). However, the Company has been advised by its financial advisor that the volatile prevailing stock market conditions in Hong Kong have been negative and are expected to affect the sentiment and appetite of investors in the Hong Kong IPO market. Having considered such market conditions, as well as the expected contribution of the Company’s new projects as previously announced, which are still either in their development or early operational stages, the board of directors of the Company (the “Board”) has decided to defer its HK IPO plan until such time as market conditions improve and the Board considers it advisable to pursue such plan. Changfeng will continue to review and monitor global stock market conditions, including in particular the Hong Kong IPO market, and update shareholders of the Company of any change in its plans as and when appropriate.

Annual Dividend and Special Dividend

Pursuant to Changfeng’s dividend policy, the Company is pleased to announce that the Board has approved the total payout for a dividend in respect of the second half of the 2018 financial year (the “Second Installment Dividend”) of approximately RMB 3,500,000 million (approximately C$690,996 based on the prevailing exchange rate between C$ and RMB at the date of this press release), an equivalent of approximately C$0.0106 (2017: C$0.0094) per common share based on the total common shares outstanding at the date of this press release.

In addition to the Second Installment Dividend, the Board has also approved the declaration of a one-time total payout for a special dividend (the “Special Dividend”) of approximately RMB 12,900,000 (approximately C$2,546,815 based on the prevailing exchange rate between C$ and RMB at the date of this press release) in recognition of the continuing support of the shareholders of the Company. The Special Dividend will be paid out in two installments, the first installment of approximately RMB 6,450,000 (approximately C$1,273,408 based on the prevailing exchange rate between C$ and RMB at the date of this press release), an equivalent of approximately C$0.0195 per common share based on the total common shares outstanding at the date of this press release, will be paid out concurrently with the Second Installment Dividend.

The Board has also approved the first installment dividend in respect of the 2019 financial year (the “2019 First Installment Dividend”) to the amount of approximately RMB 3,500,000 million (approximately C$690,996 based on the prevailing exchange rate between C$ and RMB at the date of this press release) with the payment date to be determined.

Both the Second Installment Dividend and the first installment of the Special Dividend are payable on February 26, 2019 to shareholders of record as of the close of business on February 12, 2019. Trading in the common shares of Changfeng will begin on an ex-dividend basis at the opening of trading on February 11, 2019.

The Second Installment Dividend, both installments of the Special Dividend and the 2019 First Installment Dividend will be designated as an "eligible dividend" for Canadian income tax purposes pursuant to subsection 89(14) of the Income Tax Act (Canada). Future dividends, to be approved by the Board, will be designated as an "eligible dividend" for Canadian income tax purposes unless otherwise indicated by Changfeng.

The aggregate amount of dividends to be distributed in 2019, including the Second Installment Dividend, both installments of the Special Dividend and the 2019 First Installment Dividend, aggregate to RMB 19,900,000 (approximately C$3,928,808 based on the prevailing exchange rate between C$ and RMB at the date of this press release), an equivalent of approximately C$0.0602 per common share based on the total common shares outstanding at the date of this press release.

“In appreciation of the continuing support of our investors, we have raised our semi-annual dividend for the 2018 year and declared a special dividend. I would also like to thank our shareholders for bearing with our decision to defer the HK IPO plan. It is unfortunate that market conditions are not conducive to pursuing such plan at this time.” said Huajun Lin, President, CEO and Chairman of the Company.

About Changfeng Energy Inc.

Changfeng Energy Inc. is a Canadian public company currently traded on the Toronto Venture Exchange (“TSX-V”) under the stock symbol “CFY”. It is an integrated energy provider and natural gas distribution company (or natural gas utility) in the PRC. Changfeng strives to combine leading clean energy technology with natural gas usage to provide sustainable energy to its customer base in the PRC. In 2009, Changfeng was recognized as being one of China’s the Top Ten Most Influential Brands in the Natural Gas Industry.

CONTACT INFORMATION

Corporate Investment Relations Investor.relations@changfengenergy.cn Zhaoyu.wang@changfengenergy.cn

Ann Siyin Lin VP, Corporate Development ann.lin@changfengenergy.cn Tel: +1 (647) 313 0066

Forward-Looking Statements

Certain statements contained in this news release constitute forward-looking statements and forward-looking information (collectively, “ Forward-Looking Statements ”). All statements, other than statements of historical fact, included or incorporated by reference in this document are Forward-Looking Statements, including statements regarding activities, events or developments that the Company expects or anticipates may occur in the future, including with respect to the HK IPO, the listing on the Hong Kong Stock Exchange, the expected contribution of the Company’s projects on the Group, and the timing and payment of future dividends, including a first installment dividend in respect of the 2019 financial year and a second installment of the Special Dividend. These Forward-Looking statements can be identified by the use of forward-looking words such as “will”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe” or “continue” or similar words or the negative thereof. No assurance can be given that the plans, intentions or expectations or assumptions upon which these Forward-Looking Statements are based will prove to be correct and such Forward-Looking Statements included in this news release should not be unduly relied upon.

Although management believes that the expectations represented in such Forward-Looking Statements are reasonable, there can be no assurance that such expectations will prove to be correct. Such Forward-Looking Statements are not a guarantee of performance and involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such Forward-Looking Statements. These factors include, without limitation, no significant and continuing adverse changes in general economic conditions or conditions in the financial markets. Readers are cautioned that all Forward-Looking Statements involve risks and uncertainties, including those risks and uncertainties detailed in the Company’s filings with applicable Canadian securities regulatory authorities, copies of which are available at www.sedar.com. The Company urges readers to carefully consider those factors.

The Forward-Looking Statements included in this news release are made as of the date of this document and the Company disclaims any intention or obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Brixton Metals Delivers Promising Drill Results in Thorn Project

Updated Category News Views 167

Brixton Metals' Latest Drill Results Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) recently unveiled its second batch of drill results from the 2025 exploration season. The company operates the Thorn Project, an underexplored district known for its potential in copper-gold porphyry deposits. Highlighting Impressive Assay Results The recent drilling at the...

Continue Reading
US Labor Market Stagnation: A Closer Look at 2025 Trends

Updated Category News Views 275

November Layoffs and Hiring Trends In November, layoffs by U.S. employers reduced significantly, signaling a shift in the job market dynamics. Yet, companies are still hesitant to recruit new employees, indicating a labor market that remains restrained due to various pressures. Businesses are facing challenges such as soft demand, tariff implications, and soaring...

Continue Reading
Dollar Steady Amid Global Market Uncertainty and Yuan Weakness

Updated Category News Views 127

Asian Currency Markets React to U.S. Dollar Strength In the bustling arena of Asian currencies, the atmosphere is charged with anticipation as investors monitor the situation in China regarding potential economic stimulus measures. Meanwhile, the U.S. dollar is exhibiting remarkable strength, currently hovering near a two-and-a-half month high. This rise comes in light of...

Continue Reading
Understanding Recent Insider Trades at Omega Healthcare Invts

Updated Category News Views 75

Examining Insider Trades at Omega Healthcare Invts Recently, a notable insider trade involving Omega Healthcare Invts has drawn attention. Chief Operating Officer Daniel Booth executed a significant transaction, selling 56,725 shares as disclosed through an SEC filing. This particular sale took place on a recent date and revealed a total transaction value of $2,283,181....

Continue Reading
Exploring Future Growth in Healthcare Digital Payments Market

Updated Category News Views 150

Introduction to Digital Payments in Healthcare The transformation in the realm of healthcare is not just about treatments and services; it extends deeply into how payments are managed. The Digital Payment in Healthcare Market is evolving, with an anticipated growth in value reaching USD 61,521.8 Million by the year 2033. This incredible increase is projected to occur at a...

Continue Reading